Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NEFOPAM for Analgesic intervention supportive therapy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 81 adverse event reports in the FDA FAERS database where NEFOPAM was used for Analgesic intervention supportive therapy.

Most Reported Side Effects for NEFOPAM

Side Effect Reports % Deaths Hosp.
Cholestasis 135 4.7% 2 72
Confusional state 134 4.7% 4 90
Acute kidney injury 130 4.6% 44 102
Hepatocellular injury 107 3.8% 1 69
Hepatic cytolysis 101 3.5% 0 72
Eosinophilia 97 3.4% 23 76
Rash maculo-papular 97 3.4% 23 67
Drug reaction with eosinophilia and systemic symptoms 90 3.2% 10 62
Coma 86 3.0% 4 50
Somnolence 84 2.9% 0 76
Agranulocytosis 77 2.7% 0 75
Hypotension 77 2.7% 10 50
Acute generalised exanthematous pustulosis 75 2.6% 1 59
Toxicity to various agents 69 2.4% 31 37
Death 67 2.4% 67 36

Other Indications for NEFOPAM

Pain (1,107) Product used for unknown indication (614) Analgesic therapy (115) Procedural pain (94) Pain prophylaxis (61) Anaesthesia (54) Back pain (52) Postoperative analgesia (46) Gait disturbance (45) General anaesthesia (45)

Other Drugs Used for Analgesic intervention supportive therapy

ACETAMINOPHEN (319) IBUPROFEN (181) TRAMADOL (136) KETOPROFEN (107) DICLOFENAC (75) OXYCODONE (56) PREGABALIN (52) MORPHINE (42) NAPROXEN (26) FENTANYL (25)

Related Pages

NEFOPAM Full Profile All Analgesic intervention supportive therapy Drugs NEFOPAM Demographics NEFOPAM Timeline